Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
The closing price of Caredx Inc (NASDAQ: CDNA) was $14.99 for the day, up 2.74% from the previous closing price of $14.59. In other words, the price has increased by $2.74 from its previous closing price. On the day, 1.33 million shares were traded. CDNA stock price reached its highest trading level at $15.17 during the session, while it also had its lowest trading level at $14.51.
Ratios:
Our analysis of CDNA’s different ratios will help us gain a deeper understanding of the company. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 4.28 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 67.16. For the most recent quarter (mrq), Quick Ratio is recorded 3.00 and its Current Ratio is at 3.30. In the meantime, Its Debt-to-Equity ratio is 0.09 whereas as Long-Term Debt/Eq ratio is at 0.07.
On January 15, 2025, Wells Fargo Upgraded its rating to Equal Weight which previously was Underweight and also lowered its target price recommendation from $28 to $24. On August 28, 2024, Wells Fargo started tracking the stock assigning a Underweight rating and target price of $28.Wells Fargo initiated its Underweight rating on August 28, 2024, with a $28 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Aug 05 ’25 when Novack Jeffrey Adam sold 2,688 shares for $12.79 per share. The transaction valued at 34,381 led to the insider holds 112,930 shares of the business.
Jeffrey Adam Novack bought 2,688 shares of CDNA for $33,869 on Aug 05 ’25. On Jul 07 ’25, another insider, Maag Peter, who serves as the Director of the company, sold 10,000 shares for $18.58 each. As a result, the insider received 185,831 and left with 308,846 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CDNA now has a Market Capitalization of 797871936 and an Enterprise Value of 640738944. As of this moment, Caredx’s Price-to-Earnings (P/E) ratio for their current fiscal year is 14.68. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.34 while its Price-to-Book (P/B) ratio in mrq is 2.44. Its current Enterprise Value per Revenue stands at 1.88 whereas that against EBITDA is -22.488.
Stock Price History:
The Beta on a monthly basis for CDNA is 2.37, which has changed by -0.47770035 over the last 52 weeks, in comparison to a change of 0.1675967 over the same period for the S&P500. Over the past 52 weeks, CDNA has reached a high of $32.97, while it has fallen to a 52-week low of $10.96. The 50-Day Moving Average of the stock is 12.51%, while the 200-Day Moving Average is calculated to be -18.32%.
Shares Statistics:
CDNA traded an average of 1.65M shares per day over the past three months and 1332420 shares per day over the past ten days. A total of 53.22M shares are outstanding, with a floating share count of 50.25M. Insiders hold about 5.60% of the company’s shares, while institutions hold 103.48% stake in the company. Shares short for CDNA as of 1756425600 were 6904310 with a Short Ratio of 4.19, compared to 1753920000 on 6181022. Therefore, it implies a Short% of Shares Outstanding of 6904310 and a Short% of Float of 13.28.
Earnings Estimates
Investors are eagerly awaiting the insights provided by 6.0 analysts currently analyzing and rating the stock of Caredx Inc (CDNA).The consensus estimate for the next quarter is $0.2, with high estimates of $0.23 and low estimates of $0.17.
Analysts are recommending an EPS of between $0.57 and $0.48 for the fiscal current year, implying an average EPS of $0.54. EPS for the following year is $0.8, with 6.0 analysts recommending between $0.93 and $0.73.
Revenue Estimates
It is expected that $90B in revenue will be generated in the current quarter, according to 8 analysts. It ranges from a high estimate of $96.52M to a low estimate of $93.69M. As of the current estimate, Caredx Inc’s year-ago sales were $82.88MFor the next quarter, 8 analysts are estimating revenue of $102.27M. There is a high estimate of $103.94M for the next quarter, whereas the lowest estimate is $101.42M.
A total of 8 analysts have provided revenue estimates for CDNA’s current fiscal year. The highest revenue estimate was $370.9M, while the lowest revenue estimate was $367.11M, resulting in an average revenue estimate of $368.86M. In the same quarter a year ago, actual revenue was $333.79MBased on 8 analysts’ estimates, the company’s revenue will be $412.73M in the next fiscal year. The high estimate is $425.48M and the low estimate is $394.4M.
